Coronary stents release the drug Biolimus A9 - Vietnam Registration 23454

Access comprehensive regulatory information for Coronary stents release the drug Biolimus A9 in Vietnam's medical device market through Pure Global AI's free database. is registered under number 23454 and manufactured by Biosensors Interventional Technologies Pte. Ltd.. The authorized representative in Vietnam is CPC1 Central Pharmaceutical Joint Stock Company.

This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including Biosensors Interventional Technologies Pte. Ltd., and 2 recent registrations in the same category. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.